Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.640
-0.090 (-1.90%)
At close: Feb 10, 2026, 4:00 PM EST
4.730
+0.090 (1.94%)
After-hours: Feb 10, 2026, 6:32 PM EST
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $203.79 million as of February 10, 2026. Its market cap has decreased by -48.28% in one year.
Market Cap
203.79M
Enterprise Value
202.22M
1-Year Change
-48.28%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $203.79M, a decrease of -59.74%. That is a compound annual growth rate of -16.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 204.58M | -0.86% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 504.39M |
| AngioDynamics | 435.26M |
| KORU Medical Systems | 227.91M |
| Utah Medical Products | 196.40M |
| OraSure Technologies | 194.40M |
| Stereotaxis | 189.45M |
| Sanara MedTech | 180.86M |
| Pro-Dex | 126.48M |